VivoSeq
Other

Thoracic Paravertebral Block

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Thoracic Paravertebral Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

9/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

22

clinical trials

Completed16 · 73%
Unknown status3 · 14%
Withdrawn2 · 9%
Recruiting1 · 5%

Trial Activity

22 trials

Thoracic Paravertebral Blocks in Open Nephrectomy
Completed··Phase 2·NCT03428633·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)